|
|
|
|
Inhibition of Inducible Nitric Oxide Synthase Prevents Mitochondrial Damage and Improves Survival of Steatotic Partial Liver Grafts
Background.Steatotic liver grafts are excluded for partial liver transplantation because of increased risk of primary nonfunction. Mechanisms underlying the failure of fatty partial liver grafts (FPG) remain unknown. This study...
|
|
|
Influence of Immunosuppressive Therapy on the Natural History of Genotype 3 Hepatitis-E Virus Infection After Organ Transplantation
Background.Hepatitis-E virus (HEV) infection can be responsible for chronic hepatitis in solid-organ transplant patients. Methods. We identified 33 cases of autochthonous acute HEV infection in solid-organ transplant patients. Results. Among 27 HEV...
|
|
|
Hepatitis C self-care
If you have hepatitis C your doctor needs to keep close watch on your liver function.iStockphoto.com/Lilli Day Also on the Web myOptumHealth.com tools More from myOptumHealth More>> Health More>> Latest Health News More>> Content...
|
|
|
Thymosin 4 exhibits potential as new therapeutic agent for liver failure due to chronic HBV infection
REGENERX BIOPHARMACEUTICALS, INC.(NYSE Amex:RGN) announced today that researchers have correlated T4 levels with the clinical course of patients with hepatitis B virus-related liver failure. It was reported that serum thymosin 4 levels were...
|
|
|
Entecavir (Baraclude) Improves Liver Function in Chronic Hepatitis B Patients with Decompensated Cirrhosis
Over years or decades, can progress to advanced liver disease including cirrhosis (scarring) and hepatocellular carcinoma.Compensated cirrhosis means the liver is heavily damaged but can still carry out its normal functions; decompensated...
|
|
|
Health Discovery and New York City Pancreatic Cancer Center form ...
Company: Health Discovery Corp (HDVY) Health Discovery, a molecular diagnostics company, has entered into an exclusive agreement with the Pancreas, Biliary and Liver Surgery Center of New York at Saint Vincent Catholic Medical Centers in New York City to...
|
|
|
Health Discovery and New York City Pancreatic Cancer Center form partnership
Health Discovery, a molecular diagnostics company, has entered into an exclusive agreement with the Pancreas, Biliary and Liver Surgery Center of New York at Saint Vincent Catholic Medical Centers in New York City to develop new molecular diagnostic tests...
|
|
|
Health 101:Which hospital specializes in treating cancers of the pancreas and biliary system
Saint Vincent Catholic Medical Centers(logo) Google Images If you like this ...Did you know that 1 in 72 men and women are diagnosed with cancer of the pancreas during their lifetime? The Pancreas, Biliary and Liver Surgery Center at Saint Vincent...
|
|
|
FDA liver risk warning for Bristol-Myers HIV drug
Federal health officials said Monday that patients taking a Bristol-Myers Squibb drug for HIV are at risk of a rare, but potentially fatal, liver disorder.The Food and Drug Administration said it has received 42 reports of the disorder since Videx was...
|
|
|
Conatus Pharmaceuticals Initiates Phase II Clinical Trial of CTS-1027 in Combination With Pegylated Interferon
SAN DIEGO, Jan.28 /PRNewswire/ -- Conatus Pharmaceuticals Inc. announced today the initiation of a Phase II clinical trial evaluating CTS-1027 in combination with pegylated interferon (Pegasys) and ribavirin (Copegus) in refractory HCV patients.
|
|
|
Dentistry: Recent findings from University of Suleyman Demirel highlight research in dentistry
Today's Medical & Research News Dentistry Recent findings from University of Suleyman Demirel highlight research in dentistry February 9th, 2010 Printer-Friendly Version City:Isparta Country:Turkey Dentistry Drug Development Gastroenterology Hematology...
|
|
|
Researchers Report Elevated Levels of T4 Levels Predict Patient Survival in Hepatitis B Virus-related Liver Failure
T4 - Potential New Therapeutic Agent for Liver Failure REGENERX BIOPHARMACEUTICALS, INC.(NYSE Amex:RGN) announced today that researchers have correlated T4 levels with the clinical course of patients with hepatitis B virus-related liver failure....
|
|
|
Researchers Report Elevated Levels of T4 Levels Predict Patient Survival in Hepatitis B Virus-related Liver
T4 Potential New Therapeutic Agent for Liver Failure BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC.(NYSE Amex:RGN) announced today that researchers have correlated T4 levels with the clinical course of patients with hepatitis B virus...
|
|
|
Researchers Report Elevated Levels of T4 Levels Predict Patient Survival in Hepatitis B Virus-related Liver
T4 Potential New Therapeutic Agent for Liver Failure BETHESDA, Md.--(BUSINESS WIRE)--Feb 8, 2010 - REGENERX BIOPHARMACEUTICALS, INC.(NYSE Amex:RGN) announced today that researchers have correlated T4 levels with the clinical course of patients with...
|
|
|
Researchers Report Elevated Levels of T4 Levels Predict Patient Survival in Hepatitis B Virus-related Liver Failure
T4 Potential New Therapeutic Agent for Liver Failure BETHESDA, Md.(BUSINESS WIRE) REGENERX BIOPHARMACEUTICALS, INC.(NYSE Amex:RGN) announced today that researchers have correlated T4 levels with the clinical course of patients with hepatitis B virus...
|
|
|
Researchers Report Elevated Levels of T4 Levels Predict Patient Survival in Hepatitis B Virus-related Liver Failure
T4 Potential New Therapeutic Agent for Liver Failure BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC.(NYSE Amex:RGN) announced today that researchers have correlated T4 levels with the clinical course of patients with hepatitis B virus...
|
|
|
Researchers Report Elevated Levels of TB4 Levels Predict Patient Survival in Hepatitis B Virus-related Liver F
Potential New Therapeutic Agent for Liver Failure ) BETHESDA, Md., Feb 08, 2010 (BUSINESS WIRE) -- REGENERX BIOPHARMACEUTICALS, INC.(NYSE AMEX:RGN) announced today that researchers have correlated TB4 levels with the clinical course of patients with...
|
|
|
Researchers Report Elevated Levels of T4 Levels Predict Patient Survival in Hepatitis B Virus-related Liver Failure
T4 Potential New Therapeutic Agent for Liver Failure Buzz up!Companies: Related Quotes {"s" : "rgn","k" : "c10,l10,p20,t10","o" : "","j" : ""} BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC! (NYSE Amex:RGN) announced today that...
|
|
|
Researchers Report Elevated Levels of T?4 Levels Predict Patient Survival in Hepatitis B Virus-related Liver Failure
Companies mentioned in this article: RegeneRx Biopharmaceuticals, Inc.BETHESDA, Md. -- (BUSINESS WIRE) -- REGENERX BIOPHARMACEUTICALS, INC. (NYSE Amex:RGN) announced today that researchers have correlated T4 levels with the clinical course of patients...
|
|
|
Researchers Report Elevated Levels of T4 Levels Predict Patient Survival in Hepatitis B Virus-related Liver Failure
GA_googleFillSlot("Press336"); GA_googleFillSlot("Press160"); BETHESDA, Md.- (Business Wire) REGENERX BIOPHARMACEUTICALS, INC. (NYSE Amex:RGN) announced today that researchers have correlated T4 levels with the clinical course of patients with hepatitis B...
|
|
|
Researchers Report Elevated Levels of T4 Levels Predict Patient Survival in Hepatitis B Virus-related Liver Failure
GA_googleFillSlot("Press336"); GA_googleFillSlot("Press160"); BETHESDA, Md.- (Business Wire) REGENERX BIOPHARMACEUTICALS, INC. (NYSE Amex:RGN) announced today that researchers have correlated T4 levels with the clinical course of patients with hepatitis B...
|
|
|
Researchers Report Elevated Levels of T4 Levels Predict Patient Survival in Hepatitis B Virus-related Liver
T4 Potential New Therapeutic Agent for Liver Failure BETHESDA, Md.Moreover, liver failure is a systemic inflammatory reaction, causing severe deterioration in liver function, according to the research team. Liver failure occurs when...
|
|
|
MIT, Rockefeller researchers grow hepatitis C in healthy liver cells, creating way to test new treatments for
CAMBRIDGE, Mass.-The estimated 200 million people worldwide who suffer from hepatitis C, an infectious disease affecting the liver, may soon benefit from new tests and treatments made possible by a recent discovery by researchers at the and Rockefeller...
|
|
|
Findings in hepatitis B virus reported from A. Mas and co-researchers
- (NewsRx.com) According to recent research from Barcelona, Spain, 'We assessed whether trough anti-hepatitis B surface antigen (HBs) serum levels considered to be protective (> 100 IU/L) were maintained in liver transplanted patients after 6...
|
|
|
Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavir
Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus HCV 2010 FEB 8 - (NewsRx.com) Conatus Pharmaceuticals Inc.announced the initiation of a Phase II clinical...
|
